Research record: Next generation sequencing-based measurable residual disease detection predicts outcomes in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.
Published in Haematologica; first publication date 2026-05-28. PMID 42206448.
This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.